Engineered drug resistant γδ T cells kill glioblastoma cell lines during a chemotherapy challenge: a strategy for combining chemo- and immunotherapy. [electronic resource]
Producer: 20130705Description: e51805 p. digitalISSN:- 1932-6203
- Antineoplastic Agents, Alkylating -- pharmacology
- Brain Neoplasms -- immunology
- Cell Line, Tumor
- Cell Survival -- drug effects
- Cells, Cultured
- Cytotoxicity, Immunologic -- drug effects
- Dacarbazine -- analogs & derivatives
- Diphosphonates -- pharmacology
- Drug Resistance, Neoplasm -- drug effects
- Flow Cytometry
- GPI-Linked Proteins -- immunology
- Genetic Engineering
- Genetic Vectors -- genetics
- Glioblastoma -- immunology
- Humans
- Imidazoles -- pharmacology
- Intercellular Signaling Peptides and Proteins -- immunology
- Interleukin-2 -- pharmacology
- Lentivirus -- genetics
- O(6)-Methylguanine-DNA Methyltransferase -- genetics
- Receptors, Antigen, T-Cell, gamma-delta -- immunology
- T-Lymphocytes -- immunology
- Temozolomide
- Zoledronic Acid
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.